UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 108

Sortiert nach

The world-wide burden of musculoskeletal diseases: a systematic analysis of the World Health Organization Burden of Diseases Database

Annals of the rheumatic diseases, 2019-06, Vol.78 (6), p.844

2019

Volltextzugriff (PDF)

Hydroxychloroquine in systemic lupus erythematosus: overview of current knowledge

Therapeutic Advances in Musculoskeletal Disease, 2022, Vol.14, p.1759720X211073001-1759720X211073001

2022

Volltextzugriff (PDF)

At the crossroads of gout and psoriatic arthritis: “psout”

Clinical rheumatology, 2020-05, Vol.39 (5), p.1405-1413

2020

Volltextzugriff (PDF)

Worldwide trends in all-cause mortality of auto-immune systemic diseases between 2001 and 2014

Autoimmunity reviews, 2020-06, Vol.19 (6), p.102531, Article 102531

2020

Volltextzugriff (PDF)

The 2018 pipeline of targeted therapies under clinical development for Systemic Lupus Erythematosus: a systematic review of trials

Autoimmunity reviews, 2018-08, Vol.17 (8), p.781-790

2018

Volltextzugriff (PDF)

Shared development of targeted therapies among autoimmune and inflammatory diseases: a systematic repurposing analysis

Therapeutic advances in musculoskeletal disease, 2020, Vol.12, p.1759720X20969261-1759720X20969261

2020

Volltextzugriff (PDF)

Avascular osteonecrosis in kidney transplant recipients: Risk factors in a recent cohort study and evaluation of the role of secondary hyperparathyroidism

PloS one, 2019-02, Vol.14 (2), p.e0212931-e0212931

2019

Volltextzugriff (PDF)

Is there still a place for methotrexate in severe psoriatic arthritis?

Therapeutic Advances in Musculoskeletal Disease, 2022, Vol.14, p.1759720X221092376-1759720X221092376

2022

Volltextzugriff (PDF)

Prescription strategy of antimalarials in cutaneous and systemic lupus erythematosus: an international survey

Therapeutic advances in musculoskeletal disease, 2021, Vol.13, p.1759720X211002595-1759720X211002595

2021

Volltextzugriff (PDF)

Effect of SARS-CoV-2 Vaccination on Symptoms from Post-Acute Sequelae of COVID-19: Results from the Nationwide VAXILONG Study

Vaccines (Basel), 2021-12, Vol.10 (1), p.46

2021

Volltextzugriff (PDF)

Inclusion body myositis and Sjögren's syndrome: the association works both ways

Acta neuropathologica communications, 2022-10, Vol.10 (1), p.152-152, Article 152

2022

Volltextzugriff (PDF)

Incidence and predictors of COVID-19 and flares in patients with rare autoimmune diseases: a systematic survey and serological study at a national reference center in France

Arthritis research & therapy, 2021-07, Vol.23 (1), p.1-188, Article 188

2021

Volltextzugriff (PDF)

High BTLA Expression Likely Contributes to Contraction of the Regulatory T Cell Subset in Lupus Disease

Frontiers in immunology, 2021-11, Vol.12, p.767099-767099

2021

Volltextzugriff (PDF)

The 2023 pipeline of disease-modifying antirheumatic drugs (DMARDs) in clinical development for spondyloarthritis (including psoriatic arthritis): a systematic review of trials

Rheumatic & musculoskeletal diseases open, 2023-07, Vol.9 (3), p.e003279

2023

Volltextzugriff (PDF)

10 most important contemporary challenges in the management of SLE

Lupus science & medicine, 2019-01, Vol.6 (1), p.e000303-e000303

2019

Volltextzugriff (PDF)

Immunosuppressive agents for rheumatoid arthritis: a systematic review of clinical trials and their current development stage

Therapeutic Advances in Musculoskeletal Disease, 2020, Vol.12, p.1759720X20959971-1759720X20959971

2020

Volltextzugriff (PDF)

Current Pharmacological Therapies for the Management of Spondyloarthritis: Special Considerations in Older Patients

Drugs & aging, 2023-12, Vol.40 (12), p.1101-1112

2023

Volltextzugriff (PDF)

Repurposing the Fibrosis-4 Score in Rheumatoid Arthritis: Data from the ESPOIR Cohort

Journal of clinical medicine, 2024-04, Vol.13 (7), p.1905

2024

Volltextzugriff (PDF)

Safety and efficacy of colchicine in crystal-induced arthritis flare in 54 patients with severe chronic kidney disease

Rheumatic & musculoskeletal diseases open, 2024-01, Vol.10 (1), p.e003872

2024

Volltextzugriff (PDF)

Alteration of innate lymphoid cell homeostasis mainly concerns salivary glands in primary Sjögren’s syndrome

Rheumatic & musculoskeletal diseases open, 2023-05, Vol.9 (2), p.e003051

2023

Volltextzugriff (PDF)

Impact of hyperuricaemia on patients with psoriatic arthritis treated with secukinumab in the FUTURE 2–5 and MAXIMISE studies

Rheumatic & musculoskeletal diseases open, 2023-11, Vol.9 (4), p.e003428

2023

Volltextzugriff (PDF)

Is it possible to stop glucocorticoids in systemic lupus?

Joint, bone, spine : revue du rhumatisme, 2020-12, Vol.87 (6), p.528-530

2020

Volltextzugriff (PDF)

Concordance and agreement between different activity scores in polymyalgia rheumatica

Rheumatic & musculoskeletal diseases open, 2024-03, Vol.10 (1), p.e003741

2024

Volltextzugriff (PDF)

IL-17 inhibitors in axial spondyloarthritis. An overview

Expert opinion on biological therapy, 2024-08

2024

Volltextzugriff (PDF)

Nouvelles stratégies thérapeutiques dans le lupus érythémateux systémique d’après le congrès de l’EULAR 2023

Revue du rhumatisme (Ed. française : 1993), 2024-07, Vol.91 (4), p.454-461

2024

Volltextzugriff (PDF)

1 – 25 von 108

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(92)
Mit Volltextzugriff
(98)

Publikationsform

Artikel
(104)
Berichte
(4)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

The world-wide burden of musculoskeletal diseases: a systematic analysis of the World Health Organization Burden of Diseases Database

Hydroxychloroquine in systemic lupus erythematosus: overview of current knowledge

At the crossroads of gout and psoriatic arthritis: “psout”

Worldwide trends in all-cause mortality of auto-immune systemic diseases between 2001 and 2014

The 2018 pipeline of targeted therapies under clinical development for Systemic Lupus Erythematosus: a systematic review of trials

Shared development of targeted therapies among autoimmune and inflammatory diseases: a systematic repurposing analysis

Avascular osteonecrosis in kidney transplant recipients: Risk factors in a recent cohort study and evaluation of the role of secondary hyperparathyroidism

Is there still a place for methotrexate in severe psoriatic arthritis?

Prescription strategy of antimalarials in cutaneous and systemic lupus erythematosus: an international survey

Effect of SARS-CoV-2 Vaccination on Symptoms from Post-Acute Sequelae of COVID-19: Results from the Nationwide VAXILONG Study

Inclusion body myositis and Sjögren's syndrome: the association works both ways

Incidence and predictors of COVID-19 and flares in patients with rare autoimmune diseases: a systematic survey and serological study at a national reference center in France

High BTLA Expression Likely Contributes to Contraction of the Regulatory T Cell Subset in Lupus Disease

The 2023 pipeline of disease-modifying antirheumatic drugs (DMARDs) in clinical development for spondyloarthritis (including psoriatic arthritis): a systematic review of trials

10 most important contemporary challenges in the management of SLE

Immunosuppressive agents for rheumatoid arthritis: a systematic review of clinical trials and their current development stage

Current Pharmacological Therapies for the Management of Spondyloarthritis: Special Considerations in Older Patients

Repurposing the Fibrosis-4 Score in Rheumatoid Arthritis: Data from the ESPOIR Cohort

Safety and efficacy of colchicine in crystal-induced arthritis flare in 54 patients with severe chronic kidney disease

Alteration of innate lymphoid cell homeostasis mainly concerns salivary glands in primary Sjögren’s syndrome

Impact of hyperuricaemia on patients with psoriatic arthritis treated with secukinumab in the FUTURE 2–5 and MAXIMISE studies

Is it possible to stop glucocorticoids in systemic lupus?

Concordance and agreement between different activity scores in polymyalgia rheumatica

IL-17 inhibitors in axial spondyloarthritis. An overview

Nouvelles stratégies thérapeutiques dans le lupus érythémateux systémique d’après le congrès de l’EULAR 2023

Suchergebnisse filtern